Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.

Aditya K SenguptaAparna GundaSukriti MalpaniChandra Prakash V SerkadChetana BasavarajAshok BapatManjiri M Bakre

Published in: Cancer medicine (2020)

Compared to the concordance reported for other tests, CAB shows high concordance with ODX, and in addition shows comparable performance in the patient outcomes in this cohort. CAB is thus an excellent and cost-effective alternative to ODX.

Keyphrases

clinical evaluation